MUVON Therapeutics
PrivateLast Round
Grant
Dec 12, 2025
Total Funding Raised
$22.42M
Company Overview
MUVON Therapeutics operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Grant round in December 2025.
MUVON Therapeutics is a biotechnology company developing a cell therapy platform for the regeneration of skeletal muscle tissue using a patient's own cells, with an initial focus on treating stress urinary incontinence in women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MUVON Therapeutics Comparables
Compare MUVON Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovacell Inc | 88% | |
| Cook Group Incorporated | 83% | |
| Versameb AG | 74% |
For institutional investors. Book with your work email.
MUVON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2025 | ||||
| Series A | May 31, 2021 | ||||
| Accelerator | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MUVON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wyss Zurich | Series A, Accelerator |
| Innosuisse | Grant |
| University of Zurich | Series A |
| Lichtsteiner Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors increased 89% MoM, reaching 3.5K.
- Nov 8, 2025
Monthly visitors grew 280% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
MUVON Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MUVON Therapeutics's valuation, stock price, and market status.
Is MUVON Therapeutics a public or private company?
MUVON Therapeutics is a private company.
What is the current stock price of MUVON Therapeutics?
MUVON Therapeutics is a private company, so its shares have no public market price. Caplight tracks MUVON Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MUVON Therapeutics worth (valuation)?
Valuation information for MUVON Therapeutics is not publicly available.
Can I buy MUVON Therapeutics stock?
MUVON Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MUVON Therapeutics's last funding round?
MUVON Therapeutics's most recent funding round was Grant on December 12, 2025.
Who are the main investors in MUVON Therapeutics?
Key investors in MUVON Therapeutics include Wyss Zurich.
Will MUVON Therapeutics IPO soon?
No public IPO plans have been announced for MUVON Therapeutics.
How can I track MUVON Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in MUVON Therapeutics's shares on secondary markets.